Acute Treatment of Migraine

被引：17
|
作者：
Tepper, Stewart J. [1 ,2 ,3 ]
机构：
[1] Geisel Sch Med Dartmouth, Hanover, NH USA
[2] Dartmouth Headache Ctr, Lebanon, NH USA
[3] Dartmouth Hitchcock Med Ctr, Neurol Dept, 1 Med Ctr Dr, Lebanon, NH 03748 USA
来源：
NEUROLOGIC CLINICS | 2019年 / 37卷 / 04期
关键词：
Acute migraine treatment; Migraine; Triptans; Ergots; Gepants; Ditans; NSAIDs; Neuroleptics; ACUTE TREATMENT OPTIMIZATION; DOUBLE-BLIND; PARALLEL-GROUP; EPISODIC MIGRAINE; CARE STRATEGIES; OPIOID USE; HEADACHE; PLACEBO; EFFICACY; STIMULATION;
D O I：
10.1016/j.ncl.2019.07.006
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
All patients with migraine merit acute treatment, which should optimally achieve a sustained pain-free response. Maximum acute treatment is associated with reduced risk of transformation of episodic to chronic migraine. The American Headache Society published the most recent complete evidence assessment of acute migraine treatments in 2015. Noninvasive neuromodulation represents a new, Food and Drug Administration-approved nonsignificant risk alternative for acute migraine therapy. The future of acute migraine treatment includes new devices and formulations of existing medications, new classes of acute medications, and new noninvasive nonsignificant risk neuromodulation devices, with many anticipated in the next few years.
引用
收藏
页码：727 / +
页数：17
相关论文
共 50 条
  • [21] Development of a novel zolmitriptan intracutaneous microneedle system (Qtrypta™) for the acute treatment of migraine
    Rapoport, Alan M.
    Ameri, Mahmoud
    Lewis, Hayley
    Kellerman, Donald J.
    PAIN MANAGEMENT, 2020, 10 (06) : 359 - 366
  • [22] Device profile of the Nerivio™ for acute migraine treatment: overview of its efficacy and safety
    Rapoport, Alan M.
    Lin, Tamar
    EXPERT REVIEW OF MEDICAL DEVICES, 2019, 16 (12) : 1017 - 1023
  • [23] Real-world Experience with Remote Electrical Neuromodulation in the Acute Treatment of Migraine
    Tepper, Stewart J.
    Lin, Tamar
    Montal, Tal
    Ironi, Alon
    Dougherty, Carrie
    PAIN MEDICINE, 2020, 21 (12) : 3522 - 3529
  • [24] Revisiting the Role of Ergots in the Treatment of Migraine and Headache
    Baron, Eric P.
    Tepper, Stewart J.
    HEADACHE, 2010, 50 (08): : 1353 - 1361
  • [25] Lasmiditan for the acute treatment of migraine
    DeJulio, Paul A.
    Perese, Joshua K.
    Schuster, Nathaniel M.
    Oswald, Jessica C.
    PAIN MANAGEMENT, 2021, 11 (05) : 437 - 449
  • [26] Acute Migraine Treatment in Adults
    Becker, Werner J.
    HEADACHE, 2015, 55 (06): : 778 - 793
  • [27] Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine
    Rapoport, Alan M.
    Lin, Tamar
    Tepper, Stewart J.
    HEADACHE, 2020, 60 (01): : 229 - 234
  • [28] Preventive Treatment of Migraine
    Todd, Candice M.
    Sandoe, Claire H.
    Lay, Christine
    SEMINARS IN NEUROLOGY, 2022, 42 (04) : 503 - 511
  • [29] Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? Laying the ground for the 4th edition
    Alpuente, Alicia
    Tassorelli, Cristina
    Diener, Hans-Christoph
    Silberstein, Stephen D.
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2020, 40 (08) : 778 - 787
  • [30] Ubrogepant to Treat Acute Migraine in Adults
    Edinoff, Amber N.
    Casey, C. Austin
    Colon, Marc A.
    Zaheri, Alexa R.
    Gregoire, Courtney M.
    Bourg, Margaret M.
    Kaye, Alan D.
    Kaye, Jessica S.
    Kaye, Adam M.
    Kaye, Rachel J.
    Tirumala, Sridhar R.
    Viswanath, Omar
    Urits, Ivan
    NEUROLOGY INTERNATIONAL, 2021, 13 (01): : 32 - 45
12345